Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
11.39
+0.02 (0.18%)
At close: May 12, 2025, 4:00 PM
11.13
-0.26 (-2.28%)
After-hours: May 12, 2025, 6:06 PM EDT
Axogen Market Cap
Axogen has a market cap or net worth of $518.75 million as of May 12, 2025. Its market cap has increased by 74.78% in one year.
Market Cap
518.75M
Enterprise Value
567.68M
1-Year Change
74.78%
Ranking
Category
Stock Price
$11.39
Market Cap Chart
Since December 1, 1998, Axogen's market cap has increased from $12.20M to $518.75M, an increase of 4,152.02%. That is a compound annual growth rate of 15.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 517.60M | -28.64% |
Dec 31, 2024 | 725.30M | 146.70% |
Dec 29, 2023 | 294.00M | -30.33% |
Dec 30, 2022 | 422.00M | 8.37% |
Dec 31, 2021 | 389.40M | -45.79% |
Dec 31, 2020 | 718.30M | 1.73% |
Dec 31, 2019 | 706.10M | -10.63% |
Dec 31, 2018 | 790.10M | -16.55% |
Dec 29, 2017 | 946.80M | 219.76% |
Dec 30, 2016 | 296.10M | 98.19% |
Dec 31, 2015 | 149.40M | 113.43% |
Dec 31, 2014 | 70.00M | -10.14% |
Dec 31, 2013 | 77.90M | 159.67% |
Dec 31, 2012 | 30.00M | 1.35% |
Dec 30, 2011 | 29.60M | 97.33% |
Dec 31, 2010 | 15.00M | -12.79% |
Dec 31, 2009 | 17.20M | 45.76% |
Dec 31, 2008 | 11.80M | 118.52% |
Dec 31, 2007 | 5.40M | 100.00% |
Dec 29, 2006 | 2.70M | 28.57% |
Dec 30, 2005 | 2.10M | -65.00% |
Dec 31, 2004 | 6.00M | 87.50% |
Dec 31, 2003 | 3.20M | 60.00% |
Dec 31, 2002 | 2.00M | -60.78% |
Dec 31, 2001 | 5.10M | -30.14% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.55B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |